Manrex purchases RxMedic's RM1 Pill Counting Technology

Manrex has completed is purchase of the RM1 Table-Top Pill Counter. The company has acquired the intellectual property, manufacturing assets and branding rights related to the pill counter from RxMedic. 

“RxMedic is pleased that Manrex will be taking over the RM1 business — we were looking for an organization that put customers first and we found that with Manrex,” said Matt Pike of RxMedic. “Manrex was already a proven partner, representing the RM1 in Canada very successfully for many years. Knowing the RM1 Table-Top Pill Counter will continue to expand its market presence with Manrex provides us with great peace of mind as we turn over the RM1 business to them.”

“We are absolutely thrilled to be trusted with the continued growth of the RM1 in the pharmacy marketplace” said John Webster, vice president of product innovation at Manrex. “RxMedic has done a fantastic job not only in designing the RM1 Pill Counter initially, but in developing such a strong customer following for the product with pharmacists across America. We want to build on that support and let other pharmacists know what great value the RM1 brings to pharmacies of any size and volume.”

Fiona Webster Mourant, Manrex CEO said, “As with all our product offerings, the RM1 reflects our goal of increasing the time available to the pharmacist for client counselling. Ultimately this builds stronger client rapport, provides insight into the importance of proper medication adherence and helps reduce the opportunity for medication errors. We have specialized in this area for nearly 50 years and our clients always look forward to the new innovations we are able to bring them from our network of partners around the world.”